Hemiparkinsonism-Somatic Hemiatrophy Syndrome
| Autor: | Mandar Jog, Mary Jenkins, Dan A. Mendonça, Andrew G. Parrent |
|---|---|
| Rok vydání: | 2002 |
| Předmět: | |
| Zdroj: | Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 29:184-187 |
| ISSN: | 2057-0155 0317-1671 |
| DOI: | 10.1017/s0317167100120992 |
| Popis: | Purpose:This paper highlights the hemiparkinsonism-hemiatrophy (HPHA) syndrome as a unique presentation of the parkinsonian state. Clinically relevant diagnostic and treatment aspects are reviewed.Method:We report a case of HPHA, in a 21-year-old, otherwise healthy, woman. Clinical and radiographic features of our case are presented. We also review the current literature on the clinical, radiological and pathophysiological mechanisms of HPHA.Results:In our case, despite the lack of benefit from anticholinergics and dopamine agonists (the patient declined treatment with levodopa), the patient showed a dramatic improvement with subthalamic nucleus stimulator (STN) implantation. There are no reported cases of use of STN stimulator in HPHA.Conclusion:Hemiparkinsonism-hemiatrophy is a distinct entity that may be clinically and pathogenetically different from idiopathic Parkinson’s disease; hence, HPHA needs to be considered as a possible syndrome in patients that have persistent unilateral parkinsonism. As medications are reported to be unhelpful in HPHA cases, early surgical intervention may be an option, such as in our case. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|